As GLP-1 therapies expand rapidly, understanding their systemic effects and key pharmacologic differences is essential. This session reviews common secondary system impacts, compares leading GLP-1 agents, and equips clinicians to optimize patient selection, safety, and outcomes in a fast-evolving treatment landscape.